[HTML][HTML] Enhancing interventions for prevention of mother-to-child-transmission of hepatitis B virus

PC Matthews, P Ocama, S Wang, M El-Sayed… - JHEP Reports, 2023 - Elsevier
Prevention of mother-to-child transmission of hepatitis B virus (HBV) infection is a
cornerstone of efforts to support progress towards elimination of viral hepatitis. Current …

Transient elastography for significant fibrosis in treatment-naïve CHB patients: A systematic review and meta-analysis

MN Kim, J An, EH Kim, HY Kim, HA Lee, JH Yu… - Clinical and Molecular …, 2024 - e-cmh.org
Methods The Ovid-Medline, EMBASE, Cochrane, and KoreaMed databases were searched
to identify studies that compared the performance of TE and liver biopsy (reference …

Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset

T Wang, DA Smith, C Campbell… - International Journal …, 2023 - academic.oup.com
Chronic infection with hepatitis B virus (HBV) is a global health problem, resulting in an
estimated 887000 deaths worldwide in 2015. 1 Unlike deaths from other infections such as …

Hepatitis B virus: infection, liver disease, carcinogen or syndemic threat? remodelling the clinical and public health response

PC Matthews, T Maponga, I Ghosh… - PLOS Global Public …, 2022 - journals.plos.org
Background Hepatitis B virus (HBV) is a blood-borne virus that establishes chronic liver
infection, associated with potential complications of cirrhosis and/or hepatocellular …

Is It Time for Treatment as Prevention of Chronic Hepatitis B?

JA Perez-Molina, MR Cancio-Suárez, S Moreno - Pathogens, 2023 - mdpi.com
Hepatitis B is a major global health problem with high morbidity and mortality. Approximately
296 million people are living with chronic HBV, and 1.5 million new infections are detected …

Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience

MJ Peng, XQ Guo, WL Zhang, J Chen, W Kang… - Frontiers in …, 2022 - frontiersin.org
Background and aim Controversy remains as to pegylated interferon-α (PEG-IFNα) antiviral
therapy to renal function in chronic hepatitis B (CHB) patients. The aim of this study was to …

Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania

EL Wu, B Christian, AS Rivera, E Fabian… - Journal of …, 2024 - academic.oup.com
Background An enhanced understanding of renal outcomes in persons with chronic HBV,
HIV, and HBV/HIV coinfection is needed to mitigate chronic kidney disease in regions where …

Classification of virologic trajectories during nucleos/tide analogue treatment of hepatitis B virus (HBV) infection

T Wang, C Campbell, AJ Stockdale, S Todd, K McIntyre… - medRxiv, 2023 - medrxiv.org
Background & Aims: The dynamics of HBV viral load (VL) in patients with chronic hepatitis B
(CHB) on nucleos/tide analogue (NA) treatment and its relationship with liver disease are …

Cohort Profile: National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) Research Dataset

T Wang, DA Smith, C Campbell, O Freeman… - medRxiv, 2021 - medrxiv.org
Abstract Purpose The National Institute for Health Research (NIHR) Health Informatics
Collaborative (HIC) was established to enable re-use of routinely collected clinical data …

[PDF][PDF] Renal function in patients with chronic hepatitis B during antiviral therapy.

N Čustović, L Alić, I Rašić, A Saray, A Mehmedović… - Medicinski …, 2024 - ljkzedo.ba
Aim To analyse the impact of the length of antiviral therapy with tenofovir disoproxil fumarate
(TDF) on the renal function in patients with chronic hepatitis B (CHB). Methods A cross …